BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 16093732)

  • 1. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR G677A among 594 thrombotic Jordanian patients.
    Eid SS; Shubeilat T
    Blood Coagul Fibrinolysis; 2005 Sep; 16(6):417-21. PubMed ID: 16093732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians.
    Eid SS; Rihani G
    Clin Lab Sci; 2004; 17(4):200-2. PubMed ID: 15559724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
    Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
    J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of thrombophilic genes mutations on thrombosis risk in Egyptian nonmetastatic cancer patients.
    Wahba MA; Ismail MA; Saad AA; Habashy DM; Hafeez ZM; Boshnak NH
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):309-15. PubMed ID: 25565385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.
    Mueller T; Marschon R; Dieplinger B; Haidinger D; Gegenhuber A; Poelz W; Webersinke G; Haltmayer M
    J Vasc Surg; 2005 May; 41(5):808-15. PubMed ID: 15886665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The frequency of factor V Leiden and concomitance of factor V Leiden with prothrombin G20210A mutation and methylene tetrahydrofolate reductase C677T gene mutation in healthy population of Denizli, Aegean region of Turkey.
    Kabukcu S; Keskin N; Keskin A; Atalay E
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):166-71. PubMed ID: 17456626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary thrombophilia in Mexico. II. Factor V G1691A (Leiden), prothrombin G20210A, and methylenetetrahydrofolate reductase C677T polymorphism in thrombophilic Mexican mestizos.
    Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Ramírez-Cisneros FJ
    Am J Hematol; 2001 Jan; 66(1):28-31. PubMed ID: 11426488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis.
    Eroglu A; Egin Y; Cam R; Akar N
    Ann Hematol; 2009 Jan; 88(1):73-6. PubMed ID: 18682947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.
    Kader HA; Berman WF; Al-Seraihy AS; Ware RE; Ulshen MH; Treem WR
    J Pediatr Gastroenterol Nutr; 2002 Nov; 35(5):629-35. PubMed ID: 12454577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Factor V Leiden, FII G20210A, MTHFR C677T mutations as risk factors for venous thrombosis during pregnancy and puerperium].
    Dordević V; Rakićević L; Spasić M; Miković D; Kovać M; Radojković D
    Vojnosanit Pregl; 2005 Mar; 62(3):201-5. PubMed ID: 15790048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor V Leiden G1691A, Prothrombin G20210A, and MTHFR C677T and A1298C Mutations in Patients With Sickle Cell Disease in Tunisia.
    Belhaj Nefissi R; Doggui R; Ouali F; Messaoud T; Gritli N
    Hemoglobin; 2018 Mar; 42(2):96-102. PubMed ID: 30200836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran.
    Rahimi Z; Nomani H; Mozafari H; Vaisi-Raygani A; Madani H; Malek-Khosravi S; Parsian A
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):252-6. PubMed ID: 19349859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of factor V Leiden (G1691A), prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations in Jordanian patients with beta-thalassemia major.
    Al-Sweedan SA; Jaradat S; Iraqi M; Beshtawi M
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):675-8. PubMed ID: 19710606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
    Yasa MH; Bolaman Z; Yukselen V; Kadikoylu G; Karaoglul AO; Batun S
    Hepatogastroenterology; 2007; 54(77):1438-42. PubMed ID: 17708272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. -455G/A beta-fibrinogen gene polymorphism, factor V Leiden, prothrombin G20210A mutation and MTHFR C677T, and placental vascular complications.
    Camilleri RS; Peebles D; Portmann C; Everington T; Cohen H
    Blood Coagul Fibrinolysis; 2004 Mar; 15(2):139-47. PubMed ID: 15091001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral venous and sinus thrombosis and thrombophilic mutations in Western Iran: association with factor V Leiden.
    Rahimi Z; Mozafari H; Bigvand AH; Doulabi RM; Vaisi-Raygani A; Afshari D; Razazian N; Rezaei M
    Clin Appl Thromb Hemost; 2010 Aug; 16(4):430-4. PubMed ID: 19703820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of thrombotic risk factors among beta-thalassemia patients from Western Iran.
    Rahimi Z; Ghaderi M; Nagel RL; Muniz A
    J Thromb Thrombolysis; 2008 Dec; 26(3):229-33. PubMed ID: 17982733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and MTHFR A1298C gene polymorphisms in retinopathy of prematurity in a Turkish cohort.
    Aydin H; Gunay M; Celik G; Gunay BO; Aydin UT; Karaman A
    Ophthalmic Genet; 2016 Dec; 37(4):415-418. PubMed ID: 27018927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery disease.
    Almawi WY; Ameen G; Tamim H; Finan RR; Irani-Hakime N
    J Thromb Thrombolysis; 2004 Jun; 17(3):199-205. PubMed ID: 15353918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
    Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
    N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.